NFKB1 and hepatocellular carcinoma: A recent study showed that high expression of PFKFB3 induces CD274 molecule (CD274) expression via activating the NF-κB signal pathway in monocytes, therefore inhibiting CD8+ T cell activity and poor prognosis in hepatocellular carcinoma patients [28].